SCHEMBL13548286

SCHEMBL13548286

CCCc1cc(F)cc(OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.47
CYP19A1 P11511 1/20 0.43
TAAR1 Q96RJ0 1/20 0.41
CALM1 P0DP23 3/20 0.41
AKR1B1 P15121 1/20 0.41
CYP4F2 P78329 1/20 0.40
CYP4A11 Q02928 1/20 0.40
ALDH1A1 P00352 3/20 0.39
GABRA1 P14867 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRB2 P47870 1/20 0.39
MAOB P27338 1/20 0.38
HTR2A P28223 1/20 0.37
CYP3A4 P08684 1/20 0.37
DAO P14920 1/20 0.37
HMGCR P04035 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL427550 0.85 CYP19A1 (0.55) PTGS2CYP19A1CALM1AKR1B1ALDH1A1
SCHEMBL241171 0.83 PTGS2 (0.43) PTGS2CYP19A1TAAR1CYP4F2CYP4A11
SCHEMBL23343786 0.82 CYP4F2 (0.46) PTGS2CYP19A1TAAR1CALM1AKR1B1
SCHEMBL17205092 0.82 TAAR1 (0.58) CYP19A1TAAR1MAOBHTR2A
SCHEMBL14473767 0.80 CNR1 (0.38) PTGS2TAAR1CYP3A4DAO
SCHEMBL294824 0.80 IDO1 (0.42) PTGS2TAAR1CYP3A4DAO
SCHEMBL29924049 0.79 CYP19A1 (0.51) CYP19A1TAAR1CALM1AKR1B1GABRA1
SCHEMBL28901312 0.79 CYP19A1 (0.51) CYP19A1TAAR1CALM1AKR1B1GABRA1
SCHEMBL24180144 0.79 FFAR4 (0.38) PTGS2CYP4F2CYP4A11TSHRFFAR4
SCHEMBL13980912 0.79 PTGS2 (0.50) PTGS2CYP19A1CALM1AKR1B1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170001990-A1 PIPERIDINE-DIONE DERIVATIVES GENENTECH, INC. (US) 2017-01-05 US disclosed
WO-2015140133-A1 PIPERIDINE-DIONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2015-09-24 WO disclosed
WO-2015142903-A2 METHOD OF CONTROLLING LACTATE PRODUCTION WITH PIPERDINE-DIONE DERIVATIVES GENENTECH, INC. (US) 2015-09-24 WO disclosed
US-8344138-B2 Triazinedione derivatives as GABAB receptor modulators ADDEX PHARMA S.A. (CH) 2013-01-01 US disclosed
US-20100004246-A1 NOVEL TRIAZINEDIONE DERIVATIVES AS GABAB RECEPTOR MODULATORS ADDEX PHARMA SA (CH) 2010-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004246-A1 NOVEL TRIAZINEDIONE DERIVATIVES AS GABAB RECEPTOR MODULATORS CHRNA5, GABRA5, GABRB3 PTGS2 2316/4885CYP19A1 4326/4885TAAR1 77/4885
US-20170001990-A1 PIPERIDINE-DIONE DERIVATIVES DRD4, ADORA1, ADORA3 PTGS2 2275/4885CYP19A1 646/4885TAAR1 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.